NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting FGFR1
Weilin Zhang,Zhongcheng Huang,Zhigang Xiao,Hui Wang,Qianchao Liao,Zhengru Deng,Deqing Wu,Junjiang Wang,Yong Li
DOI: https://doi.org/10.3724/abbs.2023235
IF: 3.7
2023-09-01
Acta Biochimica et Biophysica Sinica
Abstract:Despite substantial advancements in screening, surgery, and chemotherapy, colorectal cancer remains the second most lethal form of the disease. Nuclear factor kappa B (NF-κB) signaling is a critical driver facilitating the malignant transformation of chronic inflammatory bowel diseases. In this study, deregulated miRNAs that could play a role in colon cancer are analyzed and investigated for specific functions <i>in vitro</i> using cancer cells and <i>in vivo</i> using a subcutaneous xenograft model. miRNA downstream targets are analyzed, and predicted binding and regulation are verified. miR-1262, an antitumor miRNA, is downregulated in colon cancer tissue samples and cell lines. miR-1262 overexpression suppresses colon cancer malignant behaviors <i>in vitro</i> and tumor development and metastasis in a subcutaneous xenograft model and a lung metastasis mouse model <i>in vivo</i>. miR-1262 directly targets fibroblast growth factor receptor 1 (FGFR1) and inhibits FGFR1 expression. FGFR1 overexpression shows oncogenic functions through the regulation of cancer cell proliferation, invasion, and migration; when cotransfected, lv-FGFR1 partially attenuates the antitumor effects of agomir-1262. NF-κB binds to the miR-1262 promoter region and inhibits transcription activity. The NF-κB inhibitor CAPE exerts antitumor effects; miR-1262 inhibition partially reverses CAPE effects on colon cancer cells. Conclusively, miR-1262 serves as an antitumor miRNA in colon cancer by targeting FGFR1. The NF-κB/miR-1262/FGFR1 axis modulates colon cancer cell phenotypes, including proliferation, invasion, and migration.
biochemistry & molecular biology,biophysics